| Financial Year |
March 31 2023 |
| Monetary Funds |
4,468,303,127.14 |
| Held-for-trading Financial Assets |
63,104,393.73 |
| Notes Receivable |
117,707,550.51 |
| Accounts Receivable |
1,146,381,087.81 |
| Advances to Suppliers |
569,227,145.36 |
| Other Receivables |
128,833,915.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,455,993,453.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,028,055.04 |
| Other Current Assets |
53,157,646.54 |
| Total Current Assets |
8,447,517,709.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,306,144.98 |
| Long-term Equity Investment |
130,990,858.63 |
| Investment Properties |
-- |
| Fixed Assetes |
2,083,457,182.57 |
| Under-construction Projects |
72,325,638.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
485,165,561.70 |
| R&D expenses |
-- |
| Goodwill |
435,266,940.95 |
| Long-Term Deferred and Prepaid Expenses |
14,093,811.49 |
| Deferred Income Tax Assets |
111,176,967.74 |
| Other Non-Current Assets |
22,284,404.32 |
| Sub-Total of Non-Current Assets |
3,417,021,537.62 |
| Total Assets |
11,864,539,246.95 |
| Short-Term Loans |
691,850,047.73 |
| Trading Financial liabilities |
7,641,345.26 |
| Notes Payable |
564,893,324.87 |
| Accounts Payable |
818,344,312.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,031,095.30 |
| Taxes Payable |
126,754,620.22 |
| Interest Payable |
-- |
| Dividend Payable |
3,845,254.91 |
| Other payables |
66,456,628.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,724,621.17 |
| Other Current Liabilities |
9,301,883.27 |
| Sub-Total of Current Liabilities |
6,957,364,604.44 |
| Long-term Loans |
464,058,732.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
97,816,987.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
22,382,810.28 |
| Deferred Income Tax Liabilities |
63,493,137.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
735,873,342.28 |
| Total Liabilities |
7,693,237,946.72 |
| Paid-In Capital(Or Share Stock) |
942,288,735.00 |
| Capital Surplus |
2,456,349,189.13 |
| Surplus Reserve |
127,422,575.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
769,633,687.34 |
| Minority Stockholder's Interest |
144,205,360.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,027,095,940.15 |
| Owner's Equity（Stockholder's Equity） |
4,171,301,300.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,864,539,246.95 |
